Capital Allocation Trends At Healthcare Services Group (NASDAQ:HCSG) Aren't Ideal
Capital Allocation Trends At Healthcare Services Group (NASDAQ:HCSG) Aren't Ideal
When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics that can help spot trouble early. More often than not, we'll see a declining return on capital employed (ROCE) and a declining amount of capital employed. This reveals that the company isn't compounding shareholder wealth because returns are falling and its net asset base is shrinking. On that note, looking into Healthcare Services Group (NASDAQ:HCSG), we weren't too upbeat about how things were going.
在研究一家公司時,有時很難找到警告信號,但有一些財務指標可以幫助及早發現問題。往往我們會看到資本僱用回報率(ROCE)下降和資本僱用量下降。這表明公司沒有擴大股東財富,因爲回報在下降,其淨資產基礎在減少。在這一點上,查看Healthcare Services Group(納斯達克:HCSG),我們對事情的發展並不樂觀。
Return On Capital Employed (ROCE): What Is It?
資本僱用回報率(ROCE)是什麼?
For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. The formula for this calculation on Healthcare Services Group is:
對於那些不確定ROCE是什麼的人,它衡量了公司從其業務中使用的資本所能產生的稅前利潤量。在Healthcare Services Group上進行此計算的公式是:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
資產僱用回報率(ROCE)是指企業利潤,即企業稅前利潤除以企業投入的總資本(負債加股權)。如果ROCE高於企業財務成本的承受能力,那麼企業就會創造出更多的價值。
0.098 = US$60m ÷ (US$806m - US$197m) (Based on the trailing twelve months to September 2024).
0.098 = 6000萬美元 ÷ (80600萬美元 - 1.97億美元)(基於2024年9月至2024年12個月的數據)。
So, Healthcare Services Group has an ROCE of 9.8%. Even though it's in line with the industry average of 10%, it's still a low return by itself.
因此,Healthcare Services Group的ROCE爲9.8%。即使與行業平均水平10%相符合,但它仍然是一個低迴報。
Above you can see how the current ROCE for Healthcare Services Group compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free analyst report for Healthcare Services Group .
在上面,您可以看到醫療服務集團目前的資本回報率與其歷史資本回報率相比,但過去的數據僅能提供有限信息。如果您感興趣,您可以查看我們爲醫療服務集團提供的免費分析師報告中的分析師預測。
How Are Returns Trending?
綜合上述,Cimpress非常有效地提高了其資本利用率所產生的回報。考慮到股票過去五年保持穩定,如果其他指標也不錯,則可能存在機會。因此,進一步研究這家公司並確定這些趨勢是否會持續是合理的。
We are a bit worried about the trend of returns on capital at Healthcare Services Group. To be more specific, the ROCE was 16% five years ago, but since then it has dropped noticeably. On top of that, it's worth noting that the amount of capital employed within the business has remained relatively steady. Since returns are falling and the business has the same amount of assets employed, this can suggest it's a mature business that hasn't had much growth in the last five years. So because these trends aren't typically conducive to creating a multi-bagger, we wouldn't hold our breath on Healthcare Services Group becoming one if things continue as they have.
我們對醫療服務集團資本回報率的趨勢有些擔憂。具體來說,五年前的資本回報率爲16%,但自那時以來顯著下降。值得注意的是,業務中使用的資本金額保持相對穩定。由於回報率在下降且企業使用的資產量相同,這可能表明這是一個成熟的企業,在過去五年中沒有太多增長。因此,由於這些趨勢通常無法促成倍增,如果事態繼續發展如此,我們不會對醫療服務集團能夠成爲倍增者抱太大希望。
The Bottom Line
還有一件事需要注意的是,我們已經確定了上海醫藥的2個警告信號,了解這些信號應該成爲你的投資過程的一部分。
All in all, the lower returns from the same amount of capital employed aren't exactly signs of a compounding machine. Investors haven't taken kindly to these developments, since the stock has declined 51% from where it was five years ago. Unless there is a shift to a more positive trajectory in these metrics, we would look elsewhere.
總體而言,同等資本投入帶來較低迴報並不是複合機器的跡象。投資者對這些情況並不買賬,因爲股價與五年前相比下跌了51%。除非這些指標有積極的轉變趨勢,否則我們會尋找別的投資機會。
If you're still interested in Healthcare Services Group it's worth checking out our FREE intrinsic value approximation for HCSG to see if it's trading at an attractive price in other respects.
如果您仍對醫療服務集團感興趣,值得查看我們爲HCSG提供的免費內在價值估算,以查看其在其他方面是否以有吸引力的價格交易。
While Healthcare Services Group isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.
雖然醫療服務集團沒有獲得最高回報,請查看這份免費的公司列表,這些公司在權益方面獲得了高回報並擁有實力的資產負債表。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
譯文內容由第三人軟體翻譯。